• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

呼吸道合胞病毒在健康足月婴儿中的流行情况和危险因素，美国。

Respiratory Syncytial Virus Prevalence and Risk Factors among Healthy Term Infants, United States.

出版信息

Emerg Infect Dis. 2024 Oct;30(10):2199-2202. doi: 10.3201/eid3010.240609.

DOI:10.3201/eid3010.240609
PMID:39320243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11431910/
Abstract

In a population-based birth cohort study of respiratory syncytial virus surveillance in the United States, 897/1,680 (53.4%) children were infected during infancy; 25 (2.8%) of those were hospitalized. Among symptomatic infants, 143/324 (44.1%) had lower respiratory tract infections. These data provide benchmarks to monitor effects of maternal vaccines and extended half-life monoclonal antibodies.

摘要

在一项针对美国呼吸道合胞病毒监测的基于人群的出生队列研究中，1680 名儿童中有 897 名（53.4%）在婴儿期感染；其中 25 名（2.8%）住院。在有症状的婴儿中，143/324 名（44.1%）患有下呼吸道感染。这些数据为监测母体疫苗和延长半衰期单克隆抗体的效果提供了基准。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d6/11431910/60f525ba470a/24-0609-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d6/11431910/1aacc8134424/24-0609-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d6/11431910/60f525ba470a/24-0609-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d6/11431910/1aacc8134424/24-0609-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3d6/11431910/60f525ba470a/24-0609-F2.jpg

相似文献

1
Respiratory Syncytial Virus Prevalence and Risk Factors among Healthy Term Infants, United States.呼吸道合胞病毒在健康足月婴儿中的流行情况和危险因素，美国。
Emerg Infect Dis. 2024 Oct;30(10):2199-2202. doi: 10.3201/eid3010.240609.
2
Respiratory Syncytial Virus Consortium in Europe (RESCEU) Birth Cohort Study: Defining the Burden of Infant Respiratory Syncytial Virus Disease in Europe.欧洲呼吸道合胞病毒联盟（RESCEU）出生队列研究：定义欧洲婴儿呼吸道合胞病毒疾病的负担。
J Infect Dis. 2020 Oct 7;222(Suppl 7):S606-S612. doi: 10.1093/infdis/jiaa310.
3
Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024.2023 年 10 月至 2024 年 2 月，新疫苗监测网络对婴儿进入首个呼吸道合胞病毒季节时，尼赛珠单抗预防呼吸道合胞病毒相关住院的早期效果评估。
MMWR Morb Mortal Wkly Rep. 2024 Mar 7;73(9):209-214. doi: 10.15585/mmwr.mm7309a4.
4
Prevalence, risk factors and clinical characteristics of respiratory syncytial virus-associated lower respiratory tract infections in Kelantan, Malaysia.马来西亚吉兰丹州与呼吸道合胞病毒相关的下呼吸道感染的流行率、危险因素和临床特征。
J Med Virol. 2019 Sep;91(9):1608-1615. doi: 10.1002/jmv.25500. Epub 2019 May 29.
5
What U.S. Obstetricians Need to Know About Respiratory Syncytial Virus.美国妇产科医生须知：呼吸道合胞病毒
Obstet Gynecol. 2024 Mar 1;143(3):e54-e62. doi: 10.1097/AOG.0000000000005492. Epub 2023 Dec 7.
6
Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products - United States, October 2024-February 2025.呼吸道合胞病毒预防产品引入后美国婴幼儿呼吸道合胞病毒住院率的中期评估——2024年10月至2025年2月
MMWR Morb Mortal Wkly Rep. 2025 May 8;74(16):273-281. doi: 10.15585/mmwr.mm7416a1.
7
The Impact of Human Immunodeficiency Virus Exposure on Respiratory Syncytial Virus-associated Severe Respiratory Illness in South African Infants, 2011-2016.2011-2016 年南非婴儿人类免疫缺陷病毒暴露对呼吸道合胞病毒相关严重呼吸道疾病的影响。
Clin Infect Dis. 2019 Nov 27;69(12):2208-2211. doi: 10.1093/cid/ciz288.
8
Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya.在肯尼亚基利菲区对从出生起观察到的婴幼儿呼吸道合胞病毒感染及疾病情况。
Clin Infect Dis. 2008 Jan 1;46(1):50-7. doi: 10.1086/524019.
9
Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.呼吸道合胞病毒引起的严重疾病对发达国家儿童的影响。
Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S13-8; discussion S18-20. doi: 10.1097/01.inf.0000053881.47279.d9.
10
Level of maternal antibodies against respiratory syncytial virus (RSV) nucleoprotein at birth and risk of RSV very severe lower respiratory tract infection.出生时针对呼吸道合胞病毒（RSV）核蛋白的母体抗体水平与 RSV 严重下呼吸道感染风险的关系。
Influenza Other Respir Viruses. 2023 Jan;17(1):e13025. doi: 10.1111/irv.13025. Epub 2022 Oct 17.

引用本文的文献

1
Early risk identification for recurrent wheezing in children with respiratory syncytial virus infections.呼吸道合胞病毒感染儿童复发性喘息的早期风险识别
Am J Transl Res. 2025 Jul 15;17(7):5411-5422. doi: 10.62347/FBSN3075. eCollection 2025.
2
Direct Out-of-Pocket Costs of Nirsevimab Palivizumab during the First Respiratory Syncytial Virus Season: A Comparative Analysis.在首个呼吸道合胞病毒季节中，尼塞韦单抗与帕利珠单抗的直接自付费用：一项比较分析。
Infect Chemother. 2025 Jun;57(2):305-309. doi: 10.3947/ic.2025.0017. Epub 2025 Apr 15.

本文引用的文献

1
Respiratory syncytial virus infection and novel interventions.呼吸道合胞病毒感染与新型干预措施。
Nat Rev Microbiol. 2023 Nov;21(11):734-749. doi: 10.1038/s41579-023-00919-w. Epub 2023 Jul 12.
2
Respiratory syncytial virus infection during infancy and asthma during childhood in the USA (INSPIRE): a population-based, prospective birth cohort study.婴幼儿期呼吸道合胞病毒感染与儿童期哮喘（INSPIRE）：基于人群的前瞻性出生队列研究。
Lancet. 2023 May 20;401(10389):1669-1680. doi: 10.1016/S0140-6736(23)00811-5. Epub 2023 Apr 20.
3
The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study.
在欧洲，健康足月出生婴儿中的呼吸道合胞病毒负担：一项前瞻性出生队列研究。
Lancet Respir Med. 2023 Apr;11(4):341-353. doi: 10.1016/S2213-2600(22)00414-3. Epub 2022 Nov 10.
4
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.2019 年全球、区域和国家因呼吸道合胞病毒导致 5 岁以下儿童急性下呼吸道感染的疾病负担估计：系统分析。
Lancet. 2022 May 28;399(10340):2047-2064. doi: 10.1016/S0140-6736(22)00478-0. Epub 2022 May 19.
5
Influenza and respiratory syncytial virus during the COVID-19 pandemic: Time for a new paradigm?新冠疫情期间的流感和呼吸道合胞病毒：是否需要新的模式？
Pediatr Pulmonol. 2022 Jan;57(1):38-42. doi: 10.1002/ppul.25719. Epub 2021 Oct 13.
6
Respiratory syncytial virus in young children: community cohort study integrating serological surveys, questionnaire and electronic health records, Born in Bradford cohort, England, 2008 to 2013.婴幼儿呼吸道合胞病毒感染：2008 至 2013 年在英格兰布拉德福德出生队列中进行的整合血清学调查、问卷调查和电子健康记录的社区队列研究。
Euro Surveill. 2021 Feb;26(6). doi: 10.2807/1560-7917.ES.2021.26.6.2000023.
7
Performance evaluation of antibody tests for detecting infant respiratory syncytial virus infection.抗体检测在婴儿呼吸道合胞病毒感染检测中的性能评估。
J Med Virol. 2021 Jun;93(6):3439-3445. doi: 10.1002/jmv.26736. Epub 2020 Dec 29.
8
Respiratory Syncytial Virus-Associated Hospitalizations Among Young Children: 2015-2016.呼吸道合胞病毒相关的幼儿住院治疗：2015-2016 年。
Pediatrics. 2020 Jul;146(1). doi: 10.1542/peds.2019-3611. Epub 2020 Jun 16.
9
Continuous Invasion by Respiratory Viruses Observed in Rural Households During a Respiratory Syncytial Virus Seasonal Outbreak in Coastal Kenya.在肯尼亚沿海地区呼吸道合胞病毒季节性爆发期间，对农村家庭进行的连续呼吸道病毒入侵观察。
Clin Infect Dis. 2018 Oct 30;67(10):1559-1567. doi: 10.1093/cid/ciy313.
10
Objectives, design and enrollment results from the Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure Study (INSPIRE).呼吸道合胞病毒暴露后婴儿对肺部感染和哮喘的易感性研究（INSPIRE）的目标、设计与入组结果
BMC Pulm Med. 2015 Apr 30;15:45. doi: 10.1186/s12890-015-0040-0.